YGEN — Yourgene Health Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- £16.45m
- £31.98m
- £37.56m
Annual cashflow statement for Yourgene Health, fiscal year end - March 31st, GBP millions except per share, conversion factor applied.
2018 March 31st | 2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -9.48 | 3.39 | -3.38 | -12 | -3.19 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | -1.91 | -7.53 | 1.13 | 5.48 | 1.35 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.616 | -1.01 | -1.92 | -0.542 | -1.44 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -9.57 | -4.05 | -2.07 | -3.82 | 1.31 |
| Capital Expenditures | -0.163 | -1.07 | -1.36 | -3.84 | -2.66 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.471 | 0.476 | -7.67 | -3.6 | -0.826 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.634 | -0.591 | -9.03 | -7.44 | -3.48 |
| Financing Cash Flow Items | -0.016 | -0.01 | -0.163 | -0.211 | -0.508 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.19 | 5.61 | 12.6 | 15.5 | 3.61 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.02 | 0.968 | 1.51 | 4.23 | 1.43 |